|Articles|March 6, 2012

What's on Tap for eClinical

Author(s)Tim Denman

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor

August 14th 2026

© Andrii Yalanskyi - © Andrii Yalanskyi - stock.adobe.com

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

ByAndy Studna, Senior Editor

August 14th 2026

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

ByAndy Studna, Senior Editor

August 14th 2026

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

ByChi-Hui Tang, PhD

August 13th 2026

© Sergey Nivens - © Sergey Nivens - stock.adobe.com

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

ByAndy Studna, Senior Editor

August 13th 2026

Trending on Applied Clinical Trials Online

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work